Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
Recruiting · NCT02657785 · Registry updated 2020-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy | primary central nervous system lymphoma | Recruiting | Phase 2 / Phase 3 | 2020-09-09 | NCT02657785 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Navy General Hospital, Beijing | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Navy General Hospital | Beijing | China | 9 |